Sign In
Buy MRK
$119.05
-1.73 (-1.43%)
At Close: Jun 12, 2026
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Thursday, 29'th Jan 2026
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Merck's Non-Oncology Drugs Q4 Performance: What to Expect
11:15am, Wednesday, 28'th Jan 2026
MRK's focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health business sales performance.
What's Fueling The Rally In Merck Stock?
11:10am, Wednesday, 28'th Jan 2026
Merck (MRK)'s stock surged by 41% in the last six months, driven not only by a modest revenue increase but also by a significant profit jump and heightened investor confidence.
Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet
10:31am, Wednesday, 28'th Jan 2026
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Merck & Co., Inc. $MRK Shares Sold by Core Alternative Capital
05:34am, Wednesday, 28'th Jan 2026
Core Alternative Capital lessened its stake in Merck and Co., Inc. (NYSE: MRK) by 13.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchang
Merck Announces Second-Quarter 2026 Dividend
03:07pm, Tuesday, 27'th Jan 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Second-Quarter 2026 Dividend.
Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Tuesday, 27'th Jan 2026
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 Pharmaceutical Stocks Set to Rebound in 2026
10:17am, Tuesday, 27'th Jan 2026
There might be massive upside ahead for these drugmakers.
Overlooked Stock: RVMD Sells After MRK Turns Away
04:30pm, Monday, 26'th Jan 2026
Revolution Medicines (RVMD) reversed a lot of its recent rally on Monday after the Wall Street Journal reported that Merck (MRK) is no longer looking to buy the biotech firm. However, as George Tsilis
Revolution Medicines Stock Sinks After Merck Deal Talks Collapse
06:01am, Monday, 26'th Jan 2026
Merck & Co., Inc. (NYSE: MRK) has reportedly ended discussions to acquire cancer drug developer Revolution Medicines, Inc. (NASDAQ: RVMD) after the two sides disagreed on valuation.
B. Riley Wealth Advisors Inc. Cuts Stake in Merck & Co., Inc. $MRK
03:37am, Monday, 26'th Jan 2026
B. Riley Wealth Advisors Inc. lessened its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 12.8% in the undefined quarter, according to the company in its most recent filing with the Securities
Merck no longer in talks to buy Revolution Medicines, WSJ reports
03:27pm, Sunday, 25'th Jan 2026
Merck is no longer in discussions to buy cancer drug developer Revolution Medicines , the Wall Street Journal reported on Sunday.
Merck No Longer in Talks to Buy Revolution Medicines
02:30pm, Sunday, 25'th Jan 2026
The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.
Merck & Co., Inc. $MRK Shares Sold by Cullen Frost Bankers Inc.
06:00am, Sunday, 25'th Jan 2026
Cullen Frost Bankers Inc. decreased its position in shares of Merck and Co., Inc. (NYSE: MRK) by 7.0% during the undefined quarter, according to the company in its most recent disclosure with the Secu
Commerzbank Aktiengesellschaft FI Has $29.15 Million Position in Merck & Co., Inc. $MRK
05:22am, Sunday, 25'th Jan 2026
Commerzbank Aktiengesellschaft FI lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 75.1% during the undefined quarter, according to its most recent 13F filing with the Securities and E
